LOINC_NUM
stringlengths 3
8
| COMPONENT
stringlengths 2
246
| PROPERTY
stringlengths 1
29
| TIME_ASPCT
stringlengths 1
15
| SYSTEM
stringlengths 1
106
| SCALE_TYP
stringclasses 10
values | METHOD_TYP
stringlengths 1
57
⌀ | CLASS
stringlengths 2
24
| CLASSTYPE
int64 1
4
| LONG_COMMON_NAME
stringlengths 3
254
| SHORTNAME
stringlengths 2
51
⌀ | EXTERNAL_COPYRIGHT_NOTICE
stringlengths 39
2.6k
⌀ | STATUS
stringclasses 4
values | VersionFirstReleased
stringlengths 1
7
| VersionLastChanged
stringlengths 1
5
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
20318-2 | Stroke volume/Body surface area | ArVol | Pt | Heart.ventricle.left | Qn | US.2D.mitral valve.calculated | CARD.US | 2 | Left ventricular Stroke volume index by US 2D mitral valve calculated | LV SVI US.2D.MV | null | ACTIVE | 1.0m | 2.48 |
20319-0 | Stroke volume/Body surface area | ArVol | Pt | Heart.ventricle.left | Qn | US.2D.pulmonic valve flow area.calculated | CARD.US | 2 | Left ventricular Stroke volume index by US 2D pulmonic valve flow area calculated | LV SVI US.2D.PV flow area | null | ACTIVE | 1.0m | 2.29 |
20320-8 | Stroke volume/Body surface area | ArVol | Pt | Heart.ventricle.left | Qn | US.2D+Calculated by single-plane ellipse method | CARD.US | 2 | Left ventricular Stroke volume index by US.2D+Calculated by single-plane ellipse method | LV SVI US.2D+SP-EL | null | ACTIVE | 1.0m | 2.52 |
2032-1 | Carboxyhemoglobin/Hemoglobin.total | MFr | Pt | BldV | Qn | null | CHEM | 1 | Carboxyhemoglobin/Hemoglobin.total in Venous blood | COHgb MFr BldV | null | ACTIVE | 1.0 | 2.73 |
20321-6 | Stroke volume/Body surface area | ArVol | Pt | Heart.ventricle.left | Qn | US.Teichholz | CARD.US | 2 | Left ventricular Stroke volume index by US.Teichholz | LV SVI US.Teich | null | ACTIVE | 1.0m | 2.67 |
20322-4 | Stroke volume/Body surface area | ArVol | Pt | Heart.ventricle.left | Qn | US.2D.tricuspid valve.calculated | CARD.US | 2 | Left ventricular Stroke volume index by US 2D tricuspid valve calculated | LV SVI US.2D.TV | null | ACTIVE | 1.0m | 2.29 |
20323-2 | Stroke volume | Vol | Pt | Heart.ventricle.left | Qn | US.2D+Calculated | CARD.US | 2 | Left ventricular Stroke volume by US.2D+Calculated | LV SV US.2D+Calc | null | ACTIVE | 1.0m | 2.52 |
20324-0 | Stroke volume | Vol | Pt | Heart.ventricle.left | Qn | US.2D.aortic root.calculated | CARD.US | 2 | Left ventricular Stroke volume by US 2D aortic root calculated | LV SV US.2D.AO root | null | ACTIVE | 1.0m | 2.50 |
20325-7 | Stroke volume | Vol | Pt | Heart.ventricle.left | Qn | US.2D+Calculated by biplane ellipse method | CARD.US | 2 | Left ventricular Stroke volume by US.2D+Calculated by biplane ellipse method | LV SV US.2D+BP-EL | null | ACTIVE | 1.0m | 2.52 |
20326-5 | Stroke volume | Vol | Pt | Heart.ventricle.left | Qn | US.2D+Calculated by bullet method | CARD.US | 2 | Left ventricular Stroke volume by US.2D+Calculated by bullet method | LV SV US.2D+bullet | null | ACTIVE | 1.0m | 2.52 |
20327-3 | Stroke volume | Vol | Pt | Heart.ventricle.left | Qn | US.cubed.calculated | CARD.US | 2 | Left ventricular Stroke volume by US.cubed.calculated | LV SV US.cubed | null | ACTIVE | 1.0m | 2.48 |
20328-1 | Stroke volume | Vol | Pt | Heart.ventricle.left | Qn | US.2D.LVOT area.calculated | CARD.US | 2 | Left ventricular Stroke volume by US 2D left ventricular outflow tract area calculated | LV SV US.2D.LVOT area | null | ACTIVE | 1.0m | 2.48 |
20329-9 | Stroke volume | Vol | Pt | Heart.ventricle.left | Qn | US.2D.mod.biplane ellipse.calculated | CARD.US | 2 | Left ventricular Stroke volume by US 2D modified biplane ellipse calculated | LV SV US.2D.MOD-BP-EL | null | ACTIVE | 1.0m | 2.48 |
20330-7 | Stroke volume | Vol | Pt | Heart.ventricle.left | Qn | US.2D+Calculated by modified Simpson method | CARD.US | 2 | Left ventricular Stroke volume by US.2D+Calculated by modified Simpson method | LV SV US.2D+mod Simpson | null | ACTIVE | 1.0m | 2.52 |
20331-5 | Cardiac output/Heart rate.2 chamber | Vol | Pt | Heart.ventricle.left | Qn | US.2D.mod.single-plane.calculated | CARD.US | 2 | Left ventricular Stroke volume 2 chamber by US 2D modified single-plane calculated | LV Stroke volume.2cham US.2D.MOD-SP | null | ACTIVE | 1.0m | 2.48 |
20332-3 | Cardiac output/Heart rate.4 chamber | Vol | Pt | Heart.ventricle.left | Qn | US.2D.mod.single-plane.calculated | CARD.US | 2 | Left ventricular Cardiac output/Heart rate 4 chamber by US 2D modified single-plane calculated | LV Output/Heart rate.4cham US.2D.MOD-SP | null | ACTIVE | 1.0m | 2.48 |
20333-1 | Stroke volume | Vol | Pt | Heart.ventricle.left | Qn | US.2D.mitral valve flow area.calculated | CARD.US | 2 | Left ventricular Stroke volume by US 2D mitral valve flow area calculated | LV SV US.2D.MV flow area | null | ACTIVE | 1.0m | 2.44 |
20334-9 | Stroke volume | Vol | Pt | Heart.ventricle.right | Qn | US.2D.pulmonic valve flow area.calculated | CARD.US | 2 | Right ventricular Stroke volume by US 2D pulmonic valve flow area calculated | RV SV US.2D.PV flow area | null | ACTIVE | 1.0m | 2.44 |
20335-6 | Stroke volume | Vol | Pt | Heart.ventricle.left | Qn | US.2D+Calculated by single-plane ellipse method | CARD.US | 2 | Left ventricular Stroke volume by US.2D+Calculated by single-plane ellipse method | LV SV US.2D+SP-EL | null | ACTIVE | 1.0m | 2.52 |
20336-4 | Stroke volume | Vol | Pt | Heart.ventricle.left | Qn | US.Teichholz.calculated | CARD.US | 2 | Left ventricular Stroke volume by US.Teichholz.calculated | LV SV US.Teich | null | ACTIVE | 1.0m | 2.67 |
20337-2 | Stroke volume | Vol | Pt | Heart.ventricle.right | Qn | US.2D.tricuspid valve.calculated | CARD.US | 2 | Right ventricular Stroke volume by US 2D tricuspid valve calculated | RV SV US.2D.TV | null | ACTIVE | 1.0m | 2.48 |
20338-0 | Time | Time | Pt | Circulatory system.XXX | Qn | US.M-mode | CARD.US | 2 | Time by US.M-mode | Time M-mode | null | ACTIVE | 1.0m | 2.54 |
2033-9 | Carbonate | MCnc | Pt | BldA | Qn | null | CHEM | 1 | Carbonate [Mass/volume] in Arterial blood | Carbonate BldA-mCnc | null | ACTIVE | 1.0 | 2.34 |
20339-8 | Time | Time | Pt | Circulatory system.XXX | Qn | US | CARD.US | 2 | Time by US | Time US | null | ACTIVE | 1.0m | 2.48 |
20340-6 | Time 2 | Time | Pt | Circulatory system.XXX | Qn | US | CARD.US | 2 | Time 2 by US | Time 2 US | null | ACTIVE | 1.0m | 2.48 |
20341-4 | Time.XXX/Time 2.XXX | TRto | Pt | Circulatory system.XXX | Qn | US | CARD.US | 2 | Time/Time 2 by US | Time/Time 2 US | null | ACTIVE | 1.0m | 2.27 |
20342-2 | RR interval^at tricuspid flow measurement | Time | Pt | Heart | Qn | US | CARD.US | 2 | R-R interval by US --at tricuspid flow measurement | R-R interval @ TV flow US | null | ACTIVE | 1.0m | 2.48 |
20343-0 | Acceleration slope | Vel | Pt | Tricuspid valve | Qn | US | CARD.US | 2 | Tricuspid valve Acceleration slope by US | TV Accel slope US | null | ACTIVE | 1.0m | 2.27 |
20344-8 | Region crossection | Area | Pt | Tricuspid valve.annulus | Qn | US.calculated | CARD.US | 2 | Tricuspid valve annulus Region crossection [Area] by US.calculated | TV ann Region Xsection Area US Calc | null | ACTIVE | 1.0m | 2.48 |
20345-5 | Deceleration slope | Vel | Pt | Tricuspid valve | Qn | US | CARD.US | 2 | Tricuspid valve Deceleration slope [Velocity] by US | TV Decel slope US | null | ACTIVE | 1.0m | 2.27 |
20346-3 | Filling period.diastole | Time | Pt | Heart.atrium.right | Qn | US.measured | CARD.US | 2 | Right atrial Diastolic filling period by US | RA Dias fill period US.meas | null | ACTIVE | 1.0m | 2.48 |
2034-7 | Carbonate | MCnc | Pt | BldV | Qn | null | CHEM | 1 | Carbonate [Mass/volume] in Venous blood | Carbonate BldV-mCnc | null | ACTIVE | 1.0 | 2.34 |
20347-1 | Flow | Area | Pt | Tricuspid valve | Qn | US.calculated | CARD.US | 2 | Tricuspid valve Flow [Area] by US.calculated | TV Flow Area US Calc | null | ACTIVE | 1.0m | 2.27 |
20348-9 | Diameter.4 chamber | Len | Pt | Tricuspid valve.orifice | Qn | US.measured | CARD.US | 2 | Tricuspid valve orifice Diameter.4 chamber by US | TV orifice Diam 4CH US.meas | null | ACTIVE | 1.0m | 2.48 |
20349-7 | Pressure half time.velocity.max | Time | Pt | Tricuspid valve | Qn | US | CARD.US | 2 | Tricuspid valve Pressure half time velocity maximum by US | TV PHT vel max US | null | ACTIVE | 1.0m | 2.54 |
20350-5 | Blood flow velocity.mean | Vel | Pt | Tricuspid valve | Qn | US.doppler | CARD.US | 2 | Tricuspid valve Mean blood flow velocity by US.doppler | TV Vmean DOP | null | ACTIVE | 1.0m | 2.67 |
20351-3 | Blood flow velocity.max | Vel | Pt | Circulatory system.XXX | Qn | US.doppler | CARD.US | 2 | Maximum blood flow velocity by US.doppler | Vmax DOP | null | ACTIVE | 1.0m | 2.67 |
20352-1 | Blood flow velocity.mean | Vel | Pt | {Circulatory system} | Qn | US.doppler | CARD.US | 2 | Circulatory system Mean blood flow velocity by US.doppler | Circ sys Vmean DOP | null | ACTIVE | 1.0m | 2.67 |
20353-9 | Pressure gradient | PressDiff | Pt | Region of interest.XXX | Qn | US.doppler | CARD.US | 2 | Region of interest Pressure gradient by US.doppler | ROI Press grad DOP | null | ACTIVE | 1.0m | 2.67 |
2035-4 | Carbonate | MCnc | Pt | Plas | Qn | null | CHEM | 1 | Carbonate [Mass/volume] in Plasma | Carbonate Plas-mCnc | null | ACTIVE | 1.0 | 2.34 |
20354-7 | Blood velocity-time integral | Vel | Pt | Circulatory system.XXX | Qn | US.doppler | CARD.US | 2 | Blood velocity-time integral by US.doppler | VTI DOP | null | ACTIVE | 1.0m | 2.54 |
20355-4 | Blood flow 2.max | Vel | Pt | Circulatory system.XXX | Qn | US.doppler | CARD.US | 2 | Peak blood flow 2 by US.doppler | Bld flow 2.max DOP | null | ACTIVE | 1.0m | 2.48 |
20356-2 | Blood flow 2.mean | Vel | Pt | Circulatory system.XXX | Qn | US.doppler | CARD.US | 2 | Mean blood flow 2 by US.doppler | Bld flow 2.mean DOP | null | ACTIVE | 1.0m | 2.48 |
20357-0 | Pressure gradient 2 | PressDiff | Pt | Region of interest.XXX | Qn | US.doppler | CARD.US | 2 | Region of interest Pressure gradient 2 by US.doppler | ROI Press grad 2 DOP | null | ACTIVE | 1.0m | 2.67 |
20358-8 | Blood velocity-time integral 2 | Vel | Pt | Circulatory system.XXX | Qn | US.doppler | CARD.US | 2 | Blood velocity-time integral 2 by US.doppler | VTI 2 DOP | null | ACTIVE | 1.0m | 2.54 |
20359-6 | Region | Area | Pt | Heart.valve.XXX | Qn | US.doppler.VTI+Area.calculated | CARD.US | 2 | Heart valve Region [Area] by US.doppler VTI + area calculated | Valve Region Area DOP.VTI+area | null | ACTIVE | 1.0m | 2.32 |
20360-4 | Region | Area | Pt | Heart.valve.XXX | Qn | US.doppler.VTI+Diameter.calculated | CARD.US | 2 | Heart valve Region [Area] by US.doppler VTI + diameter calculated | Valve Region Area DOP.VTI+diam | null | ACTIVE | 1.0m | 2.32 |
20361-2 | Region | Area | Pt | Heart.valve.XXX | Qn | US.doppler.velocity+Area.calculated | CARD.US | 2 | Heart valve Region [Area] by US.doppler velocity + area calculated | Valve Region Area DOP.vel+area | null | ACTIVE | 1.0m | 2.32 |
2036-2 | Carbonate dehydratase | CCnc | Pt | RBC | Qn | null | CHEM | 1 | Carbonate dehydratase [Enzymatic activity/volume] in Red Blood Cells | Carbonate dehydratase RBC-cCnc | null | ACTIVE | 1.0 | 2.44 |
20362-0 | Region | Area | Pt | Heart.valve.XXX | Qn | US.doppler.velocity+Diameter.calculated | CARD.US | 2 | Heart valve Region [Area] by US.doppler velocity + diameter calculated | Valve Region Area DOP.vel+diam | null | ACTIVE | 1.0m | 2.32 |
20363-8 | Velocity slope | Vel | Pt | Circulatory system.XXX | Qn | US | CARD.US | 2 | Velocity slope by US | Vel slope US | null | ACTIVE | 1.0m | 2.27 |
20364-6 | Velocity slope 2 | Vel | Pt | Circulatory system.XXX | Qn | US | CARD.US | 2 | Velocity slope 2 by US | Vel slope 2 US | null | ACTIVE | 1.0m | 2.27 |
20365-3 | Volume.XXX/Volume 2.XXX | VFr | Pt | Region of interest.XXX | Qn | US.calculated | CARD.US | 2 | Region of interest Volume/Volume 2 by US.calculated | ROI Vol/Vol 2 VFr US Calc | null | ACTIVE | 1.0m | 2.34 |
20366-1 | Volume | Vol | Pt | Region of interest.XXX | Qn | US.2D+Calculated by area-length method | CARD.US | 2 | Region of interest Volume by US.2D+Calculated by area-length method | ROI Volume US.2D+A-L | null | ACTIVE | 1.0m | 2.52 |
20367-9 | Volume 2 | Vol | Pt | Region of interest.XXX | Qn | US.2D+Calculated by area-length method | CARD.US | 2 | Region of interest Volume 2 by US.2D+Calculated by area-length method | ROI Vol 2 US.2D+A-L | null | ACTIVE | 1.0m | 2.52 |
20368-7 | Blood flow velocity.max | Vel | Pt | Heart.interventricular septum.defect | Qn | US.doppler | CARD.US | 2 | Interventricular septal defect Maximum blood flow velocity by US.doppler | IVS defect Vmax DOP | null | ACTIVE | 1.0m | 2.67 |
20369-5 | Velocity slope.XXX/Velocity slope 2.XXX | VelRto | Pt | Circulatory system.XXX | Qn | US.doppler.calculated | CARD.US | 2 | Velocity slope/Velocity slope 2 by US.doppler calculated | Vel slope/Vel slope 2 DOP | null | ACTIVE | 1.0m | 2.69 |
2037-0 | Carcinoembryonic Ag | MCnc | Pt | CSF | Qn | null | CHEM | 1 | Carcinoembryonic Ag [Mass/volume] in Cerebral spinal fluid | CEA CSF-mCnc | null | ACTIVE | 1.0 | 2.73 |
20370-3 | Velocity-time integral.XXX | Len | Pt | Circulatory system.XXX | Qn | US.doppler | CARD.US | 2 | Velocity-time integral.XXX by US.doppler | VTI.XXX DOP | null | ACTIVE | 1.0m | 2.40 |
20371-1 | Velocity-time integral.XXX/Velocity-time integral 2.XXX | LenRto | Pt | Circulatory system.XXX | Qn | US.doppler | CARD.US | 2 | Velocity-time integral.XXX/Velocity-time integral 2 by US.doppler | VTI.XXX/VTI 2 DOP | null | ACTIVE | 1.0m | 2.67 |
20372-9 | Velocity-time integral 2.XXX | Len | Pt | Circulatory system.XXX | Qn | US.doppler | CARD.US | 2 | Velocity-time integral 2 XXX by US.doppler | VTI 2.XXX DOP | null | ACTIVE | 1.0m | 2.40 |
20373-7 | Amikacin | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | Amikacin [Susceptibility] by Method for Slow-growing mycobacteria | Amikacin Islt SlowMyco | null | ACTIVE | 1.0m | 2.73 |
20374-5 | Ampicillin+Sulbactam | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | Ampicillin+Sulbactam [Susceptibility] by Method for Slow-growing mycobacteria | Ampicillin+Sulbac Islt SlowMyco | null | ACTIVE | 1.0m | 2.26 |
20375-2 | Clarithromycin | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | Clarithromycin [Susceptibility] by Method for Slow-growing mycobacteria | Clarithro Islt SlowMyco | null | ACTIVE | 1.0m | 2.73 |
20376-0 | Clofazimine | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | Clofazimine [Susceptibility] by Method for Slow-growing mycobacteria | Clofazamine Islt SlowMyco | null | ACTIVE | 1.0m | 2.26 |
20377-8 | Ciprofloxacin | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | Ciprofloxacin [Susceptibility] by Method for Slow-growing mycobacteria | Ciprofloxacin Islt SlowMyco | null | ACTIVE | 1.0m | 2.73 |
20378-6 | Ceftizoxime | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | Ceftizoxime [Susceptibility] by Method for Slow-growing mycobacteria | Ceftizoxime Islt SlowMyco | null | ACTIVE | 1.0m | 2.26 |
20379-4 | Doxycycline | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | Doxycycline [Susceptibility] by Method for Slow-growing mycobacteria | Doxycycline Islt SlowMyco | null | ACTIVE | 1.0m | 2.26 |
20380-2 | Erythromycin | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | Erythromycin [Susceptibility] by Method for Slow-growing mycobacteria | Erythromycin Islt SlowMyco | null | ACTIVE | 1.0m | 2.26 |
20381-0 | Ethambutol | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | Ethambutol [Susceptibility] by Method for Slow-growing mycobacteria | Ethambutol Islt SlowMyco | null | ACTIVE | 1.0m | 2.26 |
20382-8 | Ethionamide | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | Ethionamide [Susceptibility] by Method for Slow-growing mycobacteria | Ethionamide Islt SlowMyco | null | ACTIVE | 1.0m | 2.26 |
20383-6 | Isoniazid | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | Isoniazid [Susceptibility] by Method for Slow-growing mycobacteria | Isoniazid Islt SlowMyco | null | ACTIVE | 1.0m | 2.26 |
20384-4 | Ofloxacin | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | Ofloxacin [Susceptibility] by Method for Slow-growing mycobacteria | Ofloxacin Islt SlowMyco | null | ACTIVE | 1.0m | 2.26 |
20385-1 | rifAMPin | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | rifAMPin [Susceptibility] by Method for Slow-growing mycobacteria | rifAMPin Islt SlowMyco | null | ACTIVE | 1.0m | 2.26 |
20386-9 | Rifabutin | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | Rifabutin [Susceptibility] by Method for Slow-growing mycobacteria | Rifabutin Islt SlowMyco | null | ACTIVE | 1.0m | 2.26 |
20387-7 | Trimethoprim+Sulfamethoxazole | Susc | Pt | Isolate | OrdQn | Method for Slow-growing mycobacteria | ABXBACT | 1 | Trimethoprim+Sulfamethoxazole [Susceptibility] by Method for Slow-growing mycobacteria | TMP SMX Islt SlowMyco | null | ACTIVE | 1.0m | 2.73 |
2038-8 | Carcinoembryonic Ag | MCnc | Pt | Semen | Qn | null | CHEM | 1 | Carcinoembryonic Ag [Mass/volume] in Semen | CEA Smn-mCnc | null | ACTIVE | 1.0 | 2.42 |
20388-5 | Nitrofurazone | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Nitrofurazone [Susceptibility] | Nitrofurazone Susc Islt | null | ACTIVE | 1.0m | 2.50 |
20389-3 | Mupirocin | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Mupirocin [Susceptibility] | Mupirocin Susc Islt | null | ACTIVE | 1.0m | 2.21 |
20390-1 | Silver sulfADIAZINE | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Silver sulfADIAZINE [Susceptibility] | Silvadene Susc Islt | null | ACTIVE | 1.0m | 2.73 |
20391-9 | Mafenide | Susc | Pt | Isolate | OrdQn | null | ABXBACT | 1 | Mafenide [Susceptibility] | Mafenide Susc Islt | null | ACTIVE | 1.0m | 2.21 |
20392-7 | Sample icteric | PrThr | Pt | Ser/Plas | Ord | null | SPEC | 1 | Sample icteric [Presence] of Serum or Plasma Qualitative | Sample Icteric SerPl Ql | null | ACTIVE | 1.0m | 2.73 |
20393-5 | Sample hemolyzed | PrThr | Pt | Ser/Plas | Ord | null | SPEC | 1 | Sample hemolyzed [Presence] of Serum or Plasma Qualitative | Sample Hemolyzed SerPl Ql | null | ACTIVE | 1.0m | 2.73 |
20394-3 | Sample lipemic | PrThr | Pt | Ser/Plas | Ord | null | SPEC | 1 | Sample lipemic [Presence] of Serum or Plasma Qualitative | Sample Lipemic SerPl Ql | null | ACTIVE | 1.0m | 2.73 |
20395-0 | Sample integrity | Type | Pt | Ser/Plas | Nom | null | SPEC | 1 | Sample integrity [Type] of Serum or Plasma | Sample Integrity SerPl | null | ACTIVE | 1.0m | 2.73 |
2039-6 | Carcinoembryonic Ag | MCnc | Pt | Ser/Plas | Qn | null | CHEM | 1 | Carcinoembryonic Ag [Mass/volume] in Serum or Plasma | CEA SerPl-mCnc | null | ACTIVE | 1.0 | 2.73 |
20396-8 | levoFLOXacin | Susc | Pt | Isolate | OrdQn | MIC | ABXBACT | 1 | levoFLOXacin [Susceptibility] by Minimum inhibitory concentration (MIC) | levoFLOXacin Islt MIC | null | ACTIVE | 1.0m | 2.73 |
20397-6 | Sparfloxacin | Susc | Pt | Isolate | OrdQn | MIC | ABXBACT | 1 | Sparfloxacin [Susceptibility] by Minimum inhibitory concentration (MIC) | Sparfloxacin Islt MIC | null | ACTIVE | 1.0m | 2.19 |
20398-4 | Nuclear Ab pattern.homogeneous | Titr | Pt | Ser | Qn | null | SERO | 1 | Homogenous nuclear Ab pattern [Titer] in Serum | ANA Homogen Titr Ser | null | ACTIVE | 1.0m | 2.73 |
20399-2 | Nuclear Ab pattern.nucleolar | Titr | Pt | Ser | Qn | null | SERO | 1 | Nucleolar nuclear Ab pattern [Titer] in Serum | ANA nucleolar Titr Ser | null | ACTIVE | 1.0m | 2.73 |
20400-8 | Nuclear Ab pattern.smooth nuclear envelope | Titr | Pt | Ser | Qn | null | SERO | 1 | Smooth nuclear envelope nuclear Ab pattern [Titer] in Serum | ANA smooth nucl env Titr Ser | null | ACTIVE | 1.0m | 2.70 |
20401-6 | Nuclear Ab pattern.speckled | Titr | Pt | Ser | Qn | null | SERO | 1 | Speckled nuclear Ab pattern [Titer] in Serum | ANA Speckled Titr Ser | null | ACTIVE | 1.0m | 2.73 |
20402-4 | Cells.CD16+CD56+ | NCnc | Pt | Bld | Qn | null | CELLMARK | 1 | CD16+CD56+ cells [#/volume] in Blood | CD16+CD56+ Cells # Bld | null | ACTIVE | 1.0m | 2.73 |
20403-2 | Fibronectin.fetal | MCnc | Pt | Vag | Qn | null | CHEM | 1 | Fibronectin.fetal [Mass/volume] in Vaginal fluid | Fibronectin Fetal Vag-mCnc | null | ACTIVE | 1.0m | 2.73 |
2040-4 | Cardiolipin | MCnc | Pt | Ser | Qn | null | COAG | 1 | Cardiolipin [Mass/volume] in Serum | Cardiolipin Ser-mCnc | null | ACTIVE | 1.0 | 2.34 |
20404-0 | Fibronectin.fetal | PrThr | Pt | Vag | Ord | null | CHEM | 1 | Fibronectin.fetal [Presence] in Vaginal fluid | Fibronectin Fetal Vag Ql | null | ACTIVE | 1.0m | 2.73 |
20405-7 | Urobilinogen | MCnc | Pt | Urine | Qn | Test strip | UA | 1 | Urobilinogen [Mass/volume] in Urine by Test strip | Urobilinogen Ur Strip-mCnc | null | ACTIVE | 1.0m | 2.73 |
20406-5 | Glucose | MFr | Pt | Urine | Qn | Test strip | UA | 1 | Deprecated Glucose [Mass/volume] in Urine by Test strip | Deprecated Glucose Fr Ur Strip | null | DEPRECATED | 1.0m | 2.70 |
20407-3 | Nitrite | MCnc | Pt | Urine | Qn | Test strip | UA | 1 | Nitrite [Mass/volume] in Urine by Test strip | Nitrite Ur Strip-mCnc | null | ACTIVE | 1.0m | 2.73 |
20408-1 | Leukocytes | NCnc | Pt | Urine | Qn | Test strip | UA | 1 | Leukocytes [#/volume] in Urine by Test strip | WBC # Ur Strip | null | ACTIVE | 1.0m | 2.73 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.